Provided by Tiger Trade Technology Pte. Ltd.

Immunic, Inc.

14.23
-0.0100-0.07%
Volume:8K
Turnover:120.42K
Market Cap:193.53M
PE:-3.56
High:14.92
Open:14.24
Low:14.23
Close:14.24
52wk High:17.43
52wk Low:5.06
Shares:13.60M
Float Shares:11.92M
Volume Ratio:1.85
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9979
EPS(LYR):-6.2414
ROE:-138.17%
ROA:-66.80%
PB:1.52
PE(LYR):-2.28

Loading ...

Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors

THOMSON REUTERS
·
May 19

Immunic (IMUX) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 18

Immunic price target lowered to $19 from $26 at Roth Capital

TIPRANKS
·
May 14

Immunic (IMUX) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 14

Immunic Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Immunic Q1 EPS $(1.08) Misses $(0.91) Estimate

Benzinga Earnings
·
May 13

Immunic Q1 Basic EPS USD -1.08

THOMSON REUTERS
·
May 13

Immunic Q1 FY26 net loss widens to $32.6 million

Reuters
·
May 13

Immunic, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 13

Immunic Inc expected to post a loss of 91 cents a share - Earnings Preview

Reuters
·
May 12

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX) and Hinge Health, Inc. Class A (HNGE)

TIPRANKS
·
May 06

Immunic Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 30

Immunic attends Bio€quity Europe investor conference in May

Reuters
·
Apr 30

Immunic price target adjusted to $22 from $5 at H.C. Wainwright

TIPRANKS
·
Apr 30

Immunic files Form 3 for Chief Medical Officer Michael A. Panzara

Reuters
·
Apr 29

Immunic names Michael Panzara chief medical officer, replacing Andreas Muehler

Reuters
·
Apr 28

BRIEF-Immunic Appoints Biopharmaceutical Executive Michael Panzara As Chief Medical Officer

Reuters
·
Apr 28

Immunic Appoints Accomplished Biopharmaceutical Executive Michael a. Panzara, M.d., M.p.h., as Chief Medical Officer

THOMSON REUTERS
·
Apr 28

Press Release: Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer

Dow Jones
·
Apr 28

Immunic trading halted, news pending

TIPRANKS
·
Apr 25